University of Benghazi Researcher Contributes to International Study Published in Q1 Journal PLOS ONE
In a new research achievement highlighting the University of Benghazi’s contribution to international research, Professor Mahmoud Werfalli, Professor of Preventive Medicine at the Faculty of Medicine, represented the University in a large-scale international research project involving researchers from several leading African universities, in collaboration with the Centre for Global Health. The project has reached an important milestone with the publication of its research protocol in PLOS ONE, a journal ranked in the first quartile (Q1) in Scopus.
The study is entitled:
The research aims to assess the potential anti-inflammatory effects of metformin in women with gestational diabetes by examining evidence from randomised controlled trials and preclinical studies involving animal pregnancy models. The review seeks to expand the scientific evidence base, inform therapeutic approaches, and contribute to improving maternal and foetal health.
The first phase of the project is scheduled to begin in January 2027, with the project expected to run for three years. It is anticipated to produce four specialised research papers covering the study’s findings, outputs, and final recommendations.




